CD8A and cancer: The deletion of this gene causes enhanced tumour growth and the coded protein facilitates the effector capability of cytotoxic T cells, pointing out that the amount and the specific type of CD8+ T cells present in a cancerous tissue contribute to the patient’s immune response to cancer.